Pharma and Biotech
Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
---|---|---|---|---|---|
30-Jun-23 | Interim | n/a | (4.32) | (0.30)p | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-18 | n/a | (1.59) | (0.40)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-19 | n/a | (1.49) | (0.40)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | n/a | (2.10) | (0.50)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (5.11) | (0.70)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | n/a | (3.99) | (0.50)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | n/a | n/a | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 1.61p |
Change Today | -0.021p |
% Change | -1.29 % |
52 Week High | 3.96 |
52 Week Low | 1.17 |
Volume | 5,063,450 |
Shares Issued | 1,341.82m |
Market Cap | £21.58m |
RiskGrade | 340 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:29 | 61,819 @ 1.62p |
16:29 | 475 @ 1.63p |
16:12 | 1,531 @ 1.62p |
16:02 | 3,067 @ 1.62p |
16:00 | 7,500 @ 1.59p |
You are here: research